Monitoring the Safety of Medicines

The Monitoring the Safety of Medicines programme is responsible for the continuous assessment and monitoring of the safety of medicines after they have been authorized for use. Through pharmacovigilance activities, ZAMRA collects, evaluates, and responds to reports of adverse drug reactions, medication errors, product quality issues, and other medicine-related safety concerns.

The programme works closely with healthcare professionals, pharmaceutical companies, patients, and international regulatory partners to identify potential risks associated with medicines and implement appropriate risk management measures. These activities help ensure that the benefits of medicines continue to outweigh any potential risks throughout their lifecycle.